• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的表观遗传变化。

Epigenetic changes in cancer.

作者信息

Iacobuzio-Donahue Christine A

机构信息

Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

出版信息

Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442.

DOI:10.1146/annurev.pathol.3.121806.151442
PMID:18840073
Abstract

Cancer is as much an epigenetic disease as it is a genetic disease, and epigenetic alterations in cancer often serve as potent surrogates for genetic mutations. Normal epigenetic modifications of DNA encompass three types of changes: chromatin modifications, DNA methylation, and genomic imprinting, each of which is altered in cancer cells. This review addresses the various epigenetic modifications that are pervasive among human tumors and traces the history of cancer epigenetics from the first observations of altered global methylation content to the recently proposed epigenetic progenitor model, which provides a common unifying mechanism for cancer development.

摘要

癌症既是一种基因疾病,也是一种表观遗传疾病,癌症中的表观遗传改变常常可作为基因突变的有力替代指标。DNA的正常表观遗传修饰包括三种类型的变化:染色质修饰、DNA甲基化和基因组印记,每一种在癌细胞中都会发生改变。本综述探讨了在人类肿瘤中普遍存在的各种表观遗传修饰,并追溯了癌症表观遗传学的历史,从首次观察到的整体甲基化含量改变,到最近提出的表观遗传祖细胞模型,该模型为癌症发展提供了一种共同的统一机制。

相似文献

1
Epigenetic changes in cancer.癌症中的表观遗传变化。
Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442.
2
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
3
Epigenetic regulation of cancer stem cell gene expression.癌症干细胞基因表达的表观遗传调控。
Subcell Biochem. 2013;61:419-34. doi: 10.1007/978-94-007-4525-4_18.
4
Cancer: an epigenetic landscape.癌症:一种表观遗传景观。
Subcell Biochem. 2013;61:399-417. doi: 10.1007/978-94-007-4525-4_17.
5
Epigenetics: surveillance team against cancer.表观遗传学:对抗癌症的监测团队。
Nature. 2005 Mar 10;434(7030):150. doi: 10.1038/434150a.
6
DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.癌症患者的DNA甲基化和组蛋白修饰:潜在的预后和治疗靶点。
Methods Mol Biol. 2007;361:25-62. doi: 10.1385/1-59745-208-4:25.
7
[Chromatin epigenetic modifications in cancer generation].[癌症发生中的染色质表观遗传修饰]
Gac Med Mex. 2002 Nov-Dec;138(6):547-55.
8
Epigenetics in prostate cancer: biologic and clinical relevance.前列腺癌中的表观遗传学:生物学和临床相关性。
Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22.
9
DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.多发性骨髓瘤中的 DNA 甲基化改变作为癌症表观遗传改变的模型。
Wiley Interdiscip Rev Syst Biol Med. 2010 Nov-Dec;2(6):654-69. doi: 10.1002/wsbm.89.
10
Epigenetic biomarkers for human cancer: the time is now.人类癌症的表观遗传生物标志物:时机已至。
Crit Rev Oncol Hematol. 2008 Oct;68(1):1-11. doi: 10.1016/j.critrevonc.2008.03.001. Epub 2008 Apr 21.

引用本文的文献

1
Immune responses and immunotherapeutic approaches in the treatment against cancer.癌症治疗中的免疫反应和免疫治疗方法。
Clin Exp Metastasis. 2024 Aug;41(4):473-493. doi: 10.1007/s10585-024-10300-7. Epub 2024 Aug 18.
2
Cancer metastasis through the lymphatic versus blood vessels.癌症通过淋巴系统和血管转移。
Clin Exp Metastasis. 2024 Aug;41(4):387-402. doi: 10.1007/s10585-024-10288-0. Epub 2024 Jun 28.
3
Gene amplification of chromatin remodeling factor and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma.
染色质重塑因子的基因扩增和ACTL6A蛋白低表达是卵巢高级别浆液性癌的不利因素。
Oncol Lett. 2024 Mar 7;27(5):196. doi: 10.3892/ol.2024.14329. eCollection 2024 May.
4
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis.社论:癌症通过淋巴血管系统转移:癌症转移的分子机制
Clin Exp Metastasis. 2024 Aug;41(4):271-273. doi: 10.1007/s10585-024-10272-8. Epub 2024 Feb 28.
5
Metastasis suppressor genes in clinical practice: are they druggable?临床实践中的转移抑制基因:它们是否具有可药用性?
Cancer Metastasis Rev. 2023 Dec;42(4):1169-1188. doi: 10.1007/s10555-023-10135-w. Epub 2023 Sep 25.
6
Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance.非小细胞肺癌中的长链非编码RNA:对表皮生长因子受体酪氨酸激酶抑制剂耐药性的影响
Front Genet. 2023 Jun 30;14:1222059. doi: 10.3389/fgene.2023.1222059. eCollection 2023.
7
Epigenetics of Fear, Anxiety and Stress - Focus on Histone Modifications.恐惧、焦虑和压力的表观遗传学 - 关注组蛋白修饰。
Curr Neuropharmacol. 2024;22(5):843-865. doi: 10.2174/1570159X21666230322154158.
8
Caregivers with Cancer Patients: Focus on Hispanics.照顾癌症患者的护理人员:关注西班牙裔。
Cancers (Basel). 2023 Jan 19;15(3):626. doi: 10.3390/cancers15030626.
9
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.泰达西那林(CI-994),一种 I 类 HDAC 抑制剂,针对 MYC 驱动的髓母细胞瘤中的内在肿瘤生长和软脑膜播散,同时通过 NF-kB-TGM2 驱动的肿瘤炎症使它们易受抗 CD47 诱导的巨噬细胞吞噬作用。
J Immunother Cancer. 2023 Jan;11(1). doi: 10.1136/jitc-2022-005871.
10
SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia.SLC22A3 甲基化介导的基因沉默预测急性髓系白血病的不良预后。
Clin Epigenetics. 2022 Dec 2;14(1):162. doi: 10.1186/s13148-022-01373-w.